Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

Gregory L. Powell; John Paul Bonadonna; Annika Vannan; Kuiying Xu; Robert H. Mach; Robert R. Luedtke; Janet Neisewander

doi:10.1016/j.pbb.2018.12.011

Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

Gregory L. Powell, John Paul Bonadonna, Annika Vannan, Kuiying Xu, Robert H. Mach, Robert R. Luedtke, Janet Neisewander

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

Original language	English (US)
Pages (from-to)	111
Number of pages	1
Journal	Pharmacology Biochemistry and Behavior
Volume	176
DOIs	https://doi.org/10.1016/j.pbb.2018.12.011
State	Published - Jan 2019

ASJC Scopus subject areas

Biochemistry
Toxicology
Pharmacology
Clinical Biochemistry
Biological Psychiatry
Behavioral Neuroscience

Access to Document

10.1016/j.pbb.2018.12.011

Fingerprint

Dive into the research topics of 'Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)'. Together they form a unique fingerprint.

Cite this

Powell, G. L., Bonadonna, J. P., Vannan, A., Xu, K., Mach, R. H., Luedtke, R. R., & Neisewander, J. (2019). Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015). Pharmacology Biochemistry and Behavior, 176, 111. https://doi.org/10.1016/j.pbb.2018.12.011

Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015). / Powell, Gregory L.; Bonadonna, John Paul; Vannan, Annika et al.
In: Pharmacology Biochemistry and Behavior, Vol. 176, 01.2019, p. 111.

Research output: Contribution to journal › Comment/debate › peer-review

Powell, GL, Bonadonna, JP, Vannan, A, Xu, K, Mach, RH, Luedtke, RR & Neisewander, J 2019, 'Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)', Pharmacology Biochemistry and Behavior, vol. 176, pp. 111. https://doi.org/10.1016/j.pbb.2018.12.011

Powell GL, Bonadonna JP, Vannan A, Xu K, Mach RH, Luedtke RR et al. Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015). Pharmacology Biochemistry and Behavior. 2019 Jan;176:111. doi: 10.1016/j.pbb.2018.12.011

@article{3d8a97766199462fa4eab35ab8b03c7c,

title = "Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)",

abstract = "This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)",

author = "Powell, {Gregory L.} and Bonadonna, {John Paul} and Annika Vannan and Kuiying Xu and Mach, {Robert H.} and Luedtke, {Robert R.} and Janet Neisewander",

note = "Publisher Copyright: {\textcopyright} 2018",

year = "2019",

month = jan,

doi = "10.1016/j.pbb.2018.12.011",

language = "English (US)",

volume = "176",

pages = "111",

journal = "Pharmacology Biochemistry and Behavior",

issn = "0091-3057",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

AU - Powell, Gregory L.

AU - Bonadonna, John Paul

AU - Vannan, Annika

AU - Xu, Kuiying

AU - Mach, Robert H.

AU - Luedtke, Robert R.

AU - Neisewander, Janet

PY - 2019/1

Y1 - 2019/1

N2 - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

AB - This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). The approved IACUC protocol used in the experiment described in this manuscript states that the dose of cocaine administered ranges up to 10 mg/kg, IP, but in this study the authors used 15 mg/kg, IP (Box 6)

UR - http://www.scopus.com/inward/record.url?scp=85059443653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059443653&partnerID=8YFLogxK

U2 - 10.1016/j.pbb.2018.12.011

DO - 10.1016/j.pbb.2018.12.011

M3 - Comment/debate

C2 - 30616777

AN - SCOPUS:85059443653

SN - 0091-3057

VL - 176

SP - 111

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

ER -

Retraction notice to “Dopamine Ds3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviors” [Pharmacology, Biochemistry and Behavior 171 (2018) 46–53](S0091305718300236)(10.1016/j.pbb.2018.05.015)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this